Naltrexone in the Treatment of Broadly Defined Behavioral Addictions: A Review and Meta-Analysis of Randomized Controlled Trials | Zendy

Fayçal Mouaffak | Zendy; Cláudio Manuel Gonçalves da Silva Leite | Zendy; Sonia Hamzaoui | Zendy; Amine Benyamina | Zendy; Xavier Laqueille | Zendy; Oussama Kébir | Zendy

Open Access

Naltrexone in the Treatment of Broadly Defined Behavioral Addictions: A Review and Meta-Analysis of Randomized Controlled Trials

Author(s) -

Fayçal Mouaffak,

Cláudio Manuel Gonçalves da Silva Leite,

Sonia Hamzaoui,

Amine Benyamina,

Xavier Laqueille,

Oussama Kébir

Publication year - 2017

Publication title -

european addiction research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.862

H-Index - 54

eISSN - 1421-9891

pISSN - 1022-6877

DOI - 10.1159/000480539

Subject(s) - naltrexone , meta analysis , addiction , randomized controlled trial , placebo , psychology , clinical psychology , psychiatry , strictly standardized mean difference , medicine , opioid , alternative medicine , receptor , pathology

Broadly defined behavioral addiction is a conceptual framework including behaviors characterized by loss of control and continuation despite significant negative consequences. Broadly defined behavioral addictions share many similarities with substance use disorders. As naltrexone is one of the most studied treatment for substance use disorders, we conducted a meta-analysis of randomized placebo-controlled trials (RCT) assessing the effectiveness of naltrexone in the treatment of broadly defined behavioral addictions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research